Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Valeant

- PMLiVE

Brexit contributes to surge in generic drug prices

Calls for government to protect pharmacies

- PMLiVE

‘No deal’ Brexit could see pharmacists take lead amid drug shortages

Government steps up preparations as Brexit day nears

- PMLiVE

As May delays, industry warns again of ‘no-deal’ Brexit

Brussels offers warm words, but no renegotiation

- PMLiVE

New Pfizer UK leader as Nordkamp moves into European role

Ben Osborn to take on managing director role

- PMLiVE

Industry frustrated by late warning on ‘no deal’ Brexit disruption

Dover and Folkestone could have 6 months of disruption

- PMLiVE

UK’s genomics leadership attracts IQVIA investment, regardless of Brexit

Invests in Genomics England alliance, plus clinical trials expansion

- PMLiVE

UK life sciences gets some Brexit relief with £1.3bn sector deal

Highlights commitments from Roche, IQVIA, Celgene and Autolus

- PMLiVE

Takeda secures investor backing for £46bn Shire takeover

The deal is expected to close early next year

- PMLiVE

Triple defeat puts May’s Brexit deal up against the wall

Prospects of a no-deal Brexit seems to loom ever larger

- PMLiVE

UK pharma Brexit pessimism deepens, as govt admits sector could be among worst hit

Political gridlock fuels fears ahead of 11 Dec vote

- PMLiVE

Shire’s angioedema drug Takhzyro claims EU approval

Approval shortly follows a green light in the US

- PMLiVE

EU27 backs Brexit terms – now the hard part starts for May

House of Commons looks set to oppose the deal

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links